Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

efgartigimod alfa and hyaluronidase-qvfc

efgartigimod alfa and hyaluronidase-qvfc
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vyvgart Hytrulo INJECTION, SUBCUTANEOUS 180 mg and 2,000 units/mL, 200 mg and 2,000 units/mL      
Comments:

Non-Formulary. Vyvgart Hytrulo is intended for patient self-administration in the home setting. Inpatients may use their home supply. Defer initiation to the outpatient setting.

 

 

Reviewed: May 2025

Updated: March 2026

 

Efgartigimod alfa and hyaluronidase (VYVGART HYTRULO) Update 2026.pdf

 

Efgartigimod alfa and hyaluronidase (VYVGART HYTRULO) Spotlight 2025.pdf

Last updated: Apr. 7, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved